Quantcast
Last updated on April 19, 2014 at 8:29 EDT

Hispanic Stroke Patients Less Likely To Receive Clot-Busting Drugs In

February 14, 2014

Abstract TMP24 (Room Hall G)

Hispanic stroke patients admitted to hospitals in the border states of California, Arizona, New Mexico and Texas were less likely than non-Hispanics in the same border states to receive clot-busting drugs and more likely to die, according to research presented at the American Stroke Association’s International Stroke Conference 2014.

Researchers analyzed stroke care for Hispanic and non-Hispanic patients according to demographics and clinical characteristics in states bordering Mexico and states not on the Mexican border. They found:

Of the nearly 35,000 Hispanic stroke patients, 21,130 were admitted in border states and 13,774 in non-border states.
Only 4.8 percent of Hispanic patients in border state hospitals received clot-busting drugs compared to 5.7 percent of non-Hispanic patients in border state hospitals.
Hispanic stroke patients were 30 percent more likely than non-Hispanics to die in border state hospitals.
There was no notable difference in death rates between Hispanic and non-Hispanic stroke patients in non-border state hospitals. Researchers say more study is needed to determine why clot-busters are underutilized in Hispanics admitted in border states but not in other states.

On the Net:


Source: American Heart Association